PPARA and metabolic dysfunction-associated steatotic liver disease: Concurrently regulating PPAR-α and NF-κB signaling, the combination intervention offers dual defense against the lipotoxicity–inflammation–oxidative stress axis that is essential to the pathophysiology of NAFLD.